Catherine Lynn Postema, AGACNP-BC | |
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3031 | |
(404) 616-1000 | |
Not Available |
Full Name | Catherine Lynn Postema |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 8 Years |
Location | 80 Jesse Hill Jr Dr Se, Atlanta, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992246557 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Emory University Hospital | Atlanta, GA | Hospital |
Grady Memorial Hospital | Atlanta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Emory Medical Care Foundation Inc | 4981501814 | 801 |
The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."
CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.
Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 7 days ago
Entity Name | The Emory Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."
CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.
Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 7 days ago
Entity Name | Emory Medical Care Foundation Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."
CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.
Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 7 days ago
Entity Name | Grady Memorial Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114243813 PECOS PAC ID: 7517032998 Enrollment ID: O20100723000311 |
News Archive
"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."
CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.
Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 7 days ago
Entity Name | Northside Primary Care Professional Services,llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922397553 PECOS PAC ID: 9638343924 Enrollment ID: O20111123000206 |
News Archive
"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."
CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.
Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Catherine Lynn Postema, AGACNP-BC 80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3050 Ph: (404) 539-9983 | Catherine Lynn Postema, AGACNP-BC 80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3031 Ph: (404) 616-1000 |
News Archive
"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."
CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.
Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 7 days ago